MYSTERIOUS: 7 - What They Never Told You

Three psychedelic drugs to undergo ‘ultra-fast’ FDA review after Trump order

The recent moves reflect growing support for the mind-altering substances among Trump’s supporters

The Independent UK · Apr 24

Trump Signs Executive Order Endorsing Psychedelic Psilocybin and Ibogaine; Asks 'Can I Have Some, Please?'

President Trump signed an executive order to expedite the review and funding of psychedelic drugs such as psilocybin and ibogaine to treat serious mental illnesses and address public health crises.

International Business Times UK · Apr 19

FDA Alert The Moringa Supplement Recall Linked to a Multi State Safety Investigation

The federal government issued an urgent health warning this morning regarding a safety failure in the supplement supply chain. The Food and Drug Administration and the Centers for Disease Control and Prevention are currently managing a multi-state investigation into contaminated dietary supplements. This investigation started after individuals reported illness across…

Grocery Coupon Guide · Apr 13

FDA’s new AI system exposes years of ‘large blind spots’ in drug and vaccine tracking

The Food and Drug Administration (FDA) just rolled out a brand-new AI-powered system designed to track adverse effects from drugs, vaccines, cosmetics, and other consumer products nationwide. This new platform, called the FDA Adverse Event Monitoring System (AEMS), went live on Tuesday, marking a massive shift in how the agency…

The Mary Sue · Mar 12

How to Check FDA and USDA Recall Lists in Under 2 Minutes Before You Cook

Feeding your family a healthy home-cooked meal is supposed to be a safe and highly rewarding daily routine. However, the massive modern industrial food supply chain is incredibly fragile, and dangerous contamination events happen constantly. Over the past year, millions of pounds of fresh produce, frozen meals, and deli meats…

Grocery Coupon Guide · Mar 10

Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants

The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency

The Independent UK · Mar 4

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule

The Independent UK · Feb 26

FDA proposes new system for approving customized drugs and therapies for rare diseases

The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases

The Independent UK · Feb 23

FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines

The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of criticism from public health experts.

The Conversation · Feb 18

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals

The Independent UK · Feb 18